Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

June 30, 2012

Study Completion Date

October 31, 2012

Conditions
HIV/HCV Co-infectionHIV Infections
Interventions
DRUG

Lopinavir/ritonavir

NRTI sparing-regimen

DRUG

Lopinavir/ritonavir with two nucleoside analogs

LPV/r plus 2NRTIs + PEG-INF + RBV

Trial Locations (10)

12004

Hospital General de Castellón, Castellon

28007

Hospital Gregorio Marañón, Madrid

28034

Hospital Ramón y Cajal, Madrid

28046

Hospital la Paz, Madrid

30203

Hospital General Sta. Mª del Rosell, Cartagena

46009

Hospital La Fe, Valencia

46014

Hospital General Universitario de Valencia, Valencia

08910

Hospital Germans Trias i Pujol, Badalona

Unknown

Hospital Donostia, Donostia / San Sebastian

Hospital La Princesa, Madrid

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Fundacion SEIMC-GESIDA

OTHER